Compton Capital Management Inc Palatin Technologies Inc Transaction History

Compton Capital Management Inc

  • $4.32 Billion
  • Q2 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 07, 2019
SELL
$0.78 - $1.09 $11,700 - $16,350
-15,000 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$0.98 - $1.64 $4,900 - $8,200
5,000 Added 50.0%
15,000 $17,000
Q2 2018

Aug 14, 2018
SELL
$0.91 - $1.45 $9,100 - $14,500
-10,000 Reduced 50.0%
10,000 $10,000
Q1 2018

May 11, 2018
BUY
$0.84 - $1.18 $5,880 - $8,260
7,000 Added 53.85%
20,000 $22,000
Q2 2017

Aug 14, 2017
BUY
N/A
13,000
13,000 $6,000

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About PALATIN TECHNOLOGIES INC

PTN Quotes by TradingView
  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $10.5M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Compton Capital Management Inc Portfolio

Follow Compton Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email